Health Condition 1: L088- Other specified local infections of the skin and subcutaneous tissue Health Condition 2: null- Patients having commen warts including palmo-plantar and periungual warts
Conditions
Interventions
Intervention1: Bleomycin: Intralesional bleomycin in warts
Intervention2: Intralesional bleomycin in warts: Bleomycin in 1mg/ml dilution not excedding 2mg in single sitting will be injected using insu
Sponsors
Dr RPGMC Tanda
Eligibility
Inclusion criteria
Inclusion criteria: patients with palmoplantar and periungual warts more than 12 years of age requiring less than 2mg of bleomycin injection
Exclusion criteria
Exclusion criteria: 1. Pregnant and lactating women 2. Children 3. Patients with Reynaudâ??s phenomenon or peripheral vascular disease 4. Patients with immune suppression from any disease or drug therapy 5. Patients with extensive warts requiring more than 2mg bleomycin
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Clearance of wartsTimepoint: Two injections of Bleomycin will be given two weeks apart and patient will be followed at 4rth and 12th week after the first injection. | — |
Secondary
| Measure | Time frame |
|---|---|
| Complete, partial or incomplete response to therapyTimepoint: Patients will be evaluated at 12 weeks to find out whether there is complete, partial or no response to treatment protocol. | — |
Countries
India
Contacts
Public ContactDr Prabal Kumar
Outcome results
None listed